Disc Medicine (IRON) Receivables - Other (2020 - 2021)

Disc Medicine (IRON) reported Receivables - Other of $6000.0 for Q1 2021, up 857042.86% quarter-over-quarter from $0.7 in Q4 2020.

Disc Medicine (IRON) Receivables - Other (2020 - 2021) Analysis & Trends

Disc Medicine (IRON) has 2 years of Receivables - Other data on file, last reported at $6000.0 in Q1 2021.

Receivables - Other for Q1 2021 came in at $6000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2021 was $6000.0 (changed N/A YoY), and the FY2020 annual result was $0.7, changed N/A from the prior year.
Receivables - Other climbed to $6000.0 in Q1 2021 per IRON's latest filing, from $0.7 in the prior quarter.
Over five years, Receivables - Other peaked at $6000.0 in Q1 2021 and troughed at $0.7 in Q4 2020.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn
9	Abivax	91.96 Bn	91.96 Bn	-
10	Disc Medicine	2.73 Bn	2.00 Bn	-

Historic Data

Download Data

Date	Value
Mar 31, 2021	6,000.00
Mar 31, 2021	6,000.00
Dec 31, 2020	0.70
Dec 31, 2020	0.70